Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Esophageal Squamous Cell Carcinoma
×
tislelizumab
×
Clear all
Filters
3
NCT05394415
2022-05-27
LATE
Jiangsu Cancer Institute & Hospital
Phase 1/2
Unknown
30 enrolled